
Cardio Diagnostics (CDIO) Holdings will host an investor conference call on Thursday, December 10, 2026, at 11 a.m. Central Time. The call will provide an overview of the Company’s precision
Compare up to 40 stocks
Compared Stocks: 1 / 40
| Ticker | Company Name | Price | Change | % Change | |
|---|---|---|---|---|---|
| CDIO | Cardio Diagnostics Holdings | 1.60 | -0.98 | -37.98% |
| Name | Price | % Change | |
|---|---|---|---|
| $1.60 | -37.98% |

Cardio Diagnostics (CDIO) Holdings will host an investor conference call on Thursday, December 10, 2026, at 11 a.m. Central Time. The call will provide an overview of the Company’s precision

Cardio Diagnostics (CDIO) Holdings released a new whitepaper, The Invisible Burden of Non-Obstructive Coronary Artery Disease: Addressing Clinical Gaps in Coronary Angiography to Improve Patient Outcomes. The whitepaper is a

Cardio Diagnostics Holdings ( ($CDIO) ) has issued an update. On September 18, 2026, Cardio Diagnostics Holdings held its annual meeting of stockholders, with approximately 60.25% of eligible shares represented,

Cardio Diagnostics (CDIO) announced the release of a new edition of the company’s rural health report, “The State of Rural Hospitals and Cardiovascular Care,” aimed at helping rural healthcare leaders,

An announcement from Cardio Diagnostics Holdings ( ($CDIO) ) is now available. On August 20, 2026, Cardio Diagnostics Holdings Inc. began using a new investor presentation to engage existing and

Cardio Diagnostics (CDIO) announced the official launch of its in-house, high complexity CLIA-certified laboratory in Iowa City, Iowa. The new facility gives Cardio Diagnostics end-to-end control over the processing of

Austin, Texas, United States, July 1st, 2026, FinanceWire Cardio Diagnostics Holdings (NASDAQ: CDIO) is a precision cardiovascular medicine company leveraging epigenetics, genetics and artificial intelligence. The company discussed innovative approaches to cardiovascular

Austin, Texas, United States, June 30th, 2026, FinanceWire Cardio Diagnostics has positioned the science of epigenetics at the center of its diagnostic platform. Looking at an individual person’s epigenetics can

Austin, Texas, United States, June 29th, 2026, FinanceWire For decades, cardiovascular risk assessment has centered on a checklist of factors never designed to capture the full biological picture of how

Austin, Texas, United States, June 24th, 2026, FinanceWire Cardio Diagnostics Holdings (NASDAQ:CDIO), an AI-powered precision cardiovascular medicine company, announced that Atlas Healthcare Physicians, an independent physician association serving managed care
Compare Stocks Side-by-Side
Our stock comparison tool allows investors to compare multiple stocks simultaneously, providing comprehensive insights into key metrics, financial data, and analyst ratings. Make informed investment decisions by analyzing stocks side by side.
Key Features of Our Stock Comparison
How to Use the Stock Comparison Tool
Simply enter the ticker symbols of the stocks you want to compare in the search box above. You can add up to 40 stocks at once. The tool will automatically populate comparison tables with the latest data, allowing you to analyze and contrast different investment opportunities across various sectors and industries.
Popular Stock Comparisons
Investors frequently compare stocks within the same sector to identify the best investment opportunities. Popular comparisons include tech giants like Apple (AAPL) vs. Microsoft (MSFT), semiconductor leaders Nvidia (NVDA) vs. AMD, beverage companies Coca-Cola (KO) vs. Pepsi (PEP), and electric vehicle makers Tesla (TSLA) vs. Rivian (RIVN).
Why Compare Stocks?
Comparing stocks helps investors identify which companies offer the best value, growth potential, and risk-adjusted returns. By analyzing multiple stocks side by side, you can better understand relative valuations, competitive advantages, and market positioning before making investment decisions.